DE3741800A1 - 17-halogenmethylen-estratriene - Google Patents

17-halogenmethylen-estratriene

Info

Publication number
DE3741800A1
DE3741800A1 DE19873741800 DE3741800A DE3741800A1 DE 3741800 A1 DE3741800 A1 DE 3741800A1 DE 19873741800 DE19873741800 DE 19873741800 DE 3741800 A DE3741800 A DE 3741800A DE 3741800 A1 DE3741800 A1 DE 3741800A1
Authority
DE
Germany
Prior art keywords
fluoromethylene
acid
chloromethylene
oestratriene
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19873741800
Other languages
German (de)
English (en)
Inventor
Peter Prof Dr Jungblut
Rudolf Prof Dr Wiechert
Rolf Dr Bohlmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Priority to DE19873741800 priority Critical patent/DE3741800A1/de
Priority to ES88730274T priority patent/ES2045176T3/es
Priority to DE8888730274T priority patent/DE3874865D1/de
Priority to AT88730274T priority patent/ATE80893T1/de
Priority to EP88730274A priority patent/EP0320438B1/de
Priority to CA000585131A priority patent/CA1324374C/en
Priority to JP63307067A priority patent/JP2636913B2/ja
Priority to AU26652/88A priority patent/AU617140B2/en
Priority to US07/280,912 priority patent/US5124321A/en
Publication of DE3741800A1 publication Critical patent/DE3741800A1/de
Priority to GR920402518T priority patent/GR3006579T3/el
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19873741800 1987-12-07 1987-12-07 17-halogenmethylen-estratriene Withdrawn DE3741800A1 (de)

Priority Applications (10)

Application Number Priority Date Filing Date Title
DE19873741800 DE3741800A1 (de) 1987-12-07 1987-12-07 17-halogenmethylen-estratriene
ES88730274T ES2045176T3 (es) 1987-12-07 1988-12-05 17-halogeno-metilen-estratrienos.
DE8888730274T DE3874865D1 (de) 1987-12-07 1988-12-05 17-halogenmethylen-estratriene.
AT88730274T ATE80893T1 (de) 1987-12-07 1988-12-05 17-halogenmethylen-estratriene.
EP88730274A EP0320438B1 (de) 1987-12-07 1988-12-05 17-Halogenmethylen-estratriene
CA000585131A CA1324374C (en) 1987-12-07 1988-12-06 17-halomethylene estratrienes
JP63307067A JP2636913B2 (ja) 1987-12-07 1988-12-06 １７−ハロゲンメチレン−エストラトリエン、その製造方法および該化合物を含有する、エストロゲン欠乏症候群の治療用医薬
AU26652/88A AU617140B2 (en) 1987-12-07 1988-12-07 17-halomethylene estratrienes
US07/280,912 US5124321A (en) 1987-12-07 1988-12-07 17-halomethylene estratrienes
GR920402518T GR3006579T3 (US06815460-20041109-C00097.png) 1987-12-07 1992-12-18

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873741800 DE3741800A1 (de) 1987-12-07 1987-12-07 17-halogenmethylen-estratriene

Publications (1)

Publication Number Publication Date
DE3741800A1 true DE3741800A1 (de) 1989-06-15

Family

ID=6342257

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19873741800 Withdrawn DE3741800A1 (de) 1987-12-07 1987-12-07 17-halogenmethylen-estratriene
DE8888730274T Expired - Lifetime DE3874865D1 (de) 1987-12-07 1988-12-05 17-halogenmethylen-estratriene.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE8888730274T Expired - Lifetime DE3874865D1 (de) 1987-12-07 1988-12-05 17-halogenmethylen-estratriene.

Country Status (9)

Country Link
US (1) US5124321A (US06815460-20041109-C00097.png)
EP (1) EP0320438B1 (US06815460-20041109-C00097.png)
JP (1) JP2636913B2 (US06815460-20041109-C00097.png)
AT (1) ATE80893T1 (US06815460-20041109-C00097.png)
AU (1) AU617140B2 (US06815460-20041109-C00097.png)
CA (1) CA1324374C (US06815460-20041109-C00097.png)
DE (2) DE3741800A1 (US06815460-20041109-C00097.png)
ES (1) ES2045176T3 (US06815460-20041109-C00097.png)
GR (1) GR3006579T3 (US06815460-20041109-C00097.png)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19509729A1 (de) * 1995-03-13 1996-09-19 Schering Ag 17-Difluormethylen-Estratriene
SE9502921D0 (sv) * 1995-08-23 1995-08-23 Astra Ab New compounds
US5773432A (en) * 1996-10-30 1998-06-30 Schering Aktiengesellschaft Method for lowering plasma levels of lipoprotein(a)
AU2005259499A1 (en) * 2004-06-29 2006-01-12 Jado Technologies Gmbh Use of steroid-derived pharmaceutical compositions for treating disorders relating to pathological processes in lipid rafts

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536703A (en) * 1968-09-11 1970-10-27 Searle & Co N - (3 - alkoxy - 19 - norpregna - 1,3,5(10),17(20) - tetraen - 21 - yl)amines and derivatives thereof
BE787343A (fr) * 1971-08-10 1973-02-09 Hoffmann La Roche Procede pour la preparation de 17-(2-halogenoethylidene)- steroides
YU243975A (en) * 1974-10-14 1982-06-30 Schering Ag Process for obtaining 7-hydroxyestradiols

Also Published As

Publication number Publication date
JPH01193295A (ja) 1989-08-03
AU2665288A (en) 1989-06-08
CA1324374C (en) 1993-11-16
EP0320438B1 (de) 1992-09-23
US5124321A (en) 1992-06-23
AU617140B2 (en) 1991-11-21
ES2045176T3 (es) 1994-01-16
JP2636913B2 (ja) 1997-08-06
EP0320438A1 (de) 1989-06-14
ATE80893T1 (de) 1992-10-15
GR3006579T3 (US06815460-20041109-C00097.png) 1993-06-30
DE3874865D1 (de) 1992-10-29

Similar Documents

Publication Publication Date Title
EP0624594B1 (de) Monomere Gallensäurederivate, Verfahren zu ihrer Herstellung und Verwendung dieser Verbindungen als Arzneimittel
EP1284273B1 (de) Estra-1,3,5(10)-trien-3-sulfamat Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
EP0648779B1 (de) Neue 11-Benzaldoxim-17beta methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3741801A1 (de) 17-methylen-estratriene
EP0320438B1 (de) 17-Halogenmethylen-estratriene
DE3628189A1 (de) Oestrogen wirksame mittel und 14,17ss-ethano-14ss-estratriene
DE3402330A1 (de) 1(alpha),2(alpha)-methylen-6-methylen- und 6(alpha)-methyl-pregnene, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
DE69815329T2 (de) Estra-5(10),7-diene mit östrogener aktivität
DE2741771A1 (de) Neue 2,2-dimethyl-19-nor-steroide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE69102082T2 (de) Ungesättigte Gallsäurederivate, Verfahren zu ihrer Herstellung und pharmazeutische Präparate diese enthaltend.
EP0034114A1 (de) 3-Desoxy-delta-15-Steroide, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Präparate
DE2336431C2 (de) 1.3-oxygenierte 8 alpha-Östratriene, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE3144049A1 (de) 16(beta)-methyl-8(alpha)-oestradiole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE1593515C3 (de) 6-Chlor-21 -fluor-1,2alpha-methylen-DeKa hoch 4,6 -pregnadiene, Verfahren zu deren Herstellung sowie diese enthaltende Mittel
DE1926043C3 (de) Neue Östrogenäther und Verfahren zu ihrer Herstellung
DE1593225C3 (de) Reine alpha- und beta-anomere, optisch aktive 3-(2'-Tetrahydropyranyloxy)-Derivate von Steroid-Östrogenen sowie Verfahren zu deren Herstellung
EP0513947B1 (de) 14Alpha,16alpha-Ethano- und 14alpha,16alpha-Ethenoestratriene
DE1793422C3 (de) 4,6-Dichlor-4,6-östradiene, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel, sowie rac-u.nat. 6-Chlor- lTbeta-acetoxy-ie-methyl-17 a-äthinyl-4,6-östradien-3-on als Ausgangsverbindungen
AT270887B (de) Verfahren zur Herstellung von neuen 9β,10α-Steroiden
DE2246462B2 (de) ihrer Herstellung sowie diese enthaltende Arzneimittel
DE2247390A1 (de) Neue 1-alkylthio-androstan-derivate
DE1793344B2 (de) 2-halogen-18-methyl-1-androstene, verfahren zu deren herstellung sowie diese enthaltende arzneimittel
DE3002746A1 (de) 1-hydroxysteroide, verfahren zu ihrer herstellung und pharmazeutische praeparate, die diese verbindungen enthalten
WO1995001988A1 (de) ORAL ESTROGEN WIRKSAME ESTER DES 14α,15α-METHYLEN-ESTRADIOLS
DE2036380A1 (de) 18 Methyl 17 alpha athmyl testosteron ester

Legal Events

Date Code Title Description
8127 New person/name/address of the applicant

Owner name: SCHERING AG, 13353 BERLIN, DE

8130 Withdrawal